%0 Generic
%A Ciruelos, E. M.
%A Villagrasa, P.
%A Oliveira, M.
%A Pernas Simon, S.
%A Cortes, J.
%A Vazquez, S.
%A Martinez, N.
%A Perello, A.
%A Bermejo De Las Heras, B.
%A Martinez, E.
%A Garau Llinas, I.
%A Mele Olive, M.
%A Montano, A.
%A Vega, E.
%A Cantos, B.
%A Echarri, M. J.
%A Pascual, T.
%A Celiz, P.
%A Gonzalez-Farre, X.
%A Prat, A.
%T Palbociclib, trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in metastatic HER2-positive and hormone receptor-positive (HER2+/HR+) breast cancer (BC) with PAM50 luminal intrinsic subtype (SOLTI-1303 PATRICIA II): A randomized phase II trial
%D 2020
%@ 0923-7534
%U https://hdl.handle.net/10668/27212
%~